Company intelligence / Profile preview

Pathologics

Aptos, California, USA

Ownership: Private
Development stage: Other

Overview

PathoLogics was a medical device company specializing in the development of innovative biopsy instruments for interventional radiology and oncology. The company's primary product, the BioPince Full Core Biopsy Instrument, featured a unique tri-axial cut-and-capture system designed to retrieve high-quality, full-core tissue samples for pathological examination. This technology aimed to improve diagnostic accuracy and reduce the number of samples required per procedure. In December 2013, PathoLogics was acquired by Argon Medical Devices, which incorporated the BioPince technology into its broader portfolio of vascular and interventional products.

Therapeutic areas: OncologyOther
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Pathologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathologics.

Explore the full profile